Xarelto 10 mg: Coadministration of XARELTO (30 mg single dose)

Coadministration of XARELTO (30 mg single dose) with the H2-receptor antagonist ranitidine (150 mg twice daily), the antacid aluminum hydroxide/magnesium hydroxide ( 10 mL) or XARELTO (20 mg single dose) with the PPI omeprazole (40 mg once daily) did not show an effect on the bioavailability and exposure of rivaroxaban. Xarelto 10 mg Tablet is a blood thinner medicine. It is used to treat and prevent blood clot formation in conditions such as deep vein thrombosis (DVT, blood clots that form in the deep veins of the body, usually in the thigh or lower leg), pulmonary embolism (PE, blood clots that block one or more arteries in the lungs), and atrial fibrillation (AFib, irregular heart rhythm that may increase the risk of blood clots). It may also be used to prevent clot formation post knee or hip surgery ... Xarelto (Rivaroxaban Film-Coated Oral Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Xarelto 20 mg once daily and Xarelto 10 mg once daily were compared with 100 mg acetylsalicylic acid once daily. The primary efficacy outcome was symptomatic recurrent VTE defined as the composite of recurrent DVT or fatal or non-fatal PE.